COTY COTY INC.
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1024305 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.2%
TTM net income YoY-47.1%
TTM EPS YoY-41.3%
Revenue 3-yr CAGR-0.1%
Net income 3-yr CAGR—
Margins
Gross margin62.6%
Operating margin-1.7%
Net margin-9.7%
FCF margin7.3%
EBITDA margin6.5%
Returns
ROE-16.7%
ROA-5.0%
ROIC (approx.)-1.2%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets66.4%
Debt / equity0.89x
Current ratio0.75x
Interest coverage-0.57x
Cash quality & payout
Operating cash flow / net income-1.07x
Accruals ratio-10.4%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.56B | $1.27B | $1.28B | $1.68B | $1.58B | $1.25B | $1.30B | $1.67B |
| Cost of revenue | $570.40M | $496.50M | $489.70M | $608.00M | $560.40M | $472.70M | $466.70M | $555.70M |
| Gross profit | $984.80M | $772.70M | $791.90M | $1.07B | $1.02B | $779.70M | $832.40M | $1.11B |
| SG&A expense | $779.60M | $744.90M | $727.00M | $842.50M | $793.50M | $720.60M | $777.50M | $797.30M |
| Operating income | $170.40M | -$42.70M | -$372.00M | $148.20M | $185.00M | $15.50M | -$280.40M | $268.20M |
| Interest expense | $37.30M | $40.60M | $39.60M | $52.40M | $51.60M | $59.70M | $50.20M | $56.70M |
| Pretax income | $157.40M | -$89.80M | -$458.90M | -$168.60M | $107.10M | -$73.50M | -$460.60M | $56.60M |
| Income tax | $45.00M | $52.50M | -$53.20M | -$52.40M | $33.10M | -$4.20M | -$58.40M | $26.00M |
| Net income | $109.50M | -$141.00M | -$408.10M | -$123.60M | $67.90M | -$68.80M | -$405.70M | $23.70M |
| EBITDA | $257.70M | $85.40M | -$242.90M | $278.30M | $279.90M | $120.20M | -$175.30M | $373.80M |
| EPS (basic) | 0.12 | — | -0.47 | -0.14 | 0.07 | — | -0.47 | 0.02 |
| EPS (diluted) | 0.12 | — | -0.47 | -0.14 | 0.07 | — | -0.47 | 0.02 |
| Weighted avg. shares (diluted) | 882.70M | — | 879.90M | 876.80M | 876.30M | — | 872.10M | 875.20M |
| Balance sheet | ||||||||
| Cash & equivalents | $210.60M | $176.10M | $257.10M | $436.70M | $273.10M | $270.40M | $259.40M | $268.60M |
| Receivables | $703.70M | $525.80M | $565.20M | $689.40M | $755.10M | $526.40M | $572.90M | $594.30M |
| Inventory | $874.50M | $838.70M | $786.30M | $778.20M | $807.50M | $794.50M | $717.30M | $705.80M |
| Current assets | $2.17B | $1.92B | $1.94B | $2.25B | $2.17B | $1.95B | $1.93B | $1.95B |
| PP&E, net | $626.40M | $650.00M | $641.80M | $659.90M | $679.10M | $709.20M | $673.90M | $673.90M |
| Goodwill | $3.80B | $3.81B | $3.81B | $4.07B | $4.07B | $4.06B | $3.90B | $3.82B |
| Intangibles | $2.73B | $2.78B | $2.86B | $3.10B | $3.18B | $3.21B | $3.10B | $3.42B |
| Total assets | $10.35B | $10.20B | $10.23B | $11.08B | $12.06B | $11.91B | $11.47B | $11.72B |
| Current liabilities | $2.88B | $2.54B | $2.36B | $2.84B | $2.55B | $2.54B | $2.36B | $2.75B |
| Short-term debt | $2.10M | $14.40M | $2.10M | $2.40M | $2.70M | $3.50M | $9.40M | $14.40M |
| Long-term debt | $2.75B | $3.03B | $3.17B | $2.99B | $4.02B | $3.96B | $3.80B | $3.39B |
| Total debt | $2.75B | $3.05B | $3.17B | $2.99B | $4.02B | $3.96B | $3.81B | $3.40B |
| Total liabilities | $6.87B | $6.82B | $6.73B | $7.13B | $8.00B | $7.95B | $7.55B | $7.51B |
| Shareholders' equity | $3.11B | $2.99B | $3.09B | $3.53B | $3.64B | $3.54B | $3.50B | $3.78B |
| Net debt | $2.54B | $2.87B | $2.91B | $2.55B | $3.75B | $3.69B | $3.55B | $3.13B |
| Shares outstanding | 880.70M | 880.50M | 880.00M | 877.60M | 873.90M | 872.30M | 872.30M | 872.00M |
| Cash flow statement | ||||||||
| Operating cash flow | $130.40M | $116.00M | -$203.10M | $559.70M | $65.20M | $83.20M | -$122.50M | $464.50M |
| Capital expenditure | $45.80M | $43.40M | $45.60M | $46.60M | $54.00M | $48.30M | $45.90M | $45.50M |
| Free cash flow | $84.60M | $72.60M | -$248.70M | $513.10M | $11.20M | $34.90M | -$168.40M | $419.00M |
| Investing cash flow | $204.20M | -$74.10M | -$45.60M | $712.50M | -$53.80M | -$48.30M | $28.10M | -$30.90M |
| Financing cash flow | -$299.50M | -$125.20M | $70.50M | -$1.10B | -$7.60M | -$42.70M | $77.20M | -$450.90M |
| Depreciation & amortization | $87.30M | $128.10M | $129.10M | $130.10M | $94.90M | $104.70M | $105.10M | $105.60M |
| Stock-based compensation | $7.20M | $7.10M | $6.80M | $19.90M | $14.50M | $5.30M | $12.20M | $18.40M |
| Dividends paid | — | — | $3.30M | — | — | — | $3.20M | $3.40M |
Free plan shows the latest 8 periods; Pro shows all 57 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.